Allopartis Biotechnologies
Latest round
- Seed
Last raised
- Nov 2008
Total raised
- $0.8M
Investors
- 2
About Allopartis Biotechnologies
Allopartis Biotechnologies Inc.Allopartis Biotechnologies Inc. specializes in innovative biotechnology solutions and was founded in San Francisco, US.Allopartis specializes in innovative solutions within the biotechnology sector, focusing on the development and distribution of advanced biologic therapies. Their core product offerings include a range of therapeutic agents designed to address complex health conditions through targeted biological mechanisms. The company’s products aim to enhance patient outcomes by improving the efficacy of treatments while minimizing side effects, thereby catering to healthcare providers and patients alike. End users primarily include hospitals, clinics, and healthcare professionals who administer these therapies, targeting markets across North America, Europe, and parts of Asia.Allopartis generates revenue through a structured model that encompasses partnerships with healthcare providers and distributors. The company engages in direct sales of its flagship biologic therapies, which are typically offered through both B2B transactions with hospitals and clinics, and potentially via direct-to-consumer channels in select markets. Revenue is structured around product sales, with potential for recurring income through subscription models for ongoing treatment regimens. In this scenario, a healthcare provider may establish a partnership with Allopartis to supply its therapies, thus committing to regular orders to ensure consistent patient access to these important treatments.Allopartis Biotechnologies Inc. plans to expand its product line with new biologic therapies designed to meet specific medical needs, with a launch timeline yet to be announced. The company is also looking to penetrate additional markets in Europe and Asia by 2025.75 mn will be utilized to support product development and market expansion efforts, particularly targeting regions where the demand for advanced biologic therapies is rapidly increasing.
Who invested in Allopartis Biotechnologies
2 investors across 1 round
See all investors in Allopartis Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 5, 2008
Amount
$0.8M
Investors
Questions about Allopartis Biotechnologies
Who invested in Allopartis Biotechnologies?
Allopartis Biotechnologies has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allopartis Biotechnologies raised?
Allopartis Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Allopartis Biotechnologies last raise money?
Allopartis Biotechnologies's most recent round on record is a Seed, in Nov 2008.
What does Allopartis Biotechnologies do?
Allopartis Biotechnologies Inc.
Where is Allopartis Biotechnologies headquartered?
Allopartis Biotechnologies is headquartered in San Francisco, US.
Which VCs invest in companies like Allopartis Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allopartis Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Allopartis Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.